The Compounding Center Inc.

Phoenix, AZ

UEI
J69ERCPB7369
CAGE
4QSF3
Primary NAICS
424210 Drugs and Druggists' Sundries Merchant Wholesalers
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Minority Owned Business
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Hispanic American Owned
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1110 E McDowell Rd, Phoenix, AZ 85006, USA
Website
tccpharma.com
Founded
2001
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $0
FY2025 $0
FY2024 -$26,080
FY2023 $79,875

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

The Compounding Center Inc. is a minority owned, self-certified small disadvantaged business that provides specialized pharmaceuticals and compounded medications. As a for-profit Subchapter S corporation, the company delivers chemical compounds, drugs, and medical supplies to government agencies through federal contract awards.

The contractor has received over $700,000 in firm fixed price purchase orders and blanket purchase agreement calls from the Department of Health and Human Services and Defense Health Agency to supply pharmaceuticals, vaccines, blood collection tubes, and shortage drugs for military and civilian treatment facilities. Performance has taken place at locations across the U.S., with the majority of contract work occurring in Bethesda, Maryland. While some awards utilized total small business set asides, most have had no set-aside designation. The Compounding Center has provided specialized mixtures of pharmaceuticals to address shortages impacting patient care at hospitals and clinics managed by the funding agencies.

The Defense Health Agency awarded The Compounding Center a $6.5 million single award blanket purchase agreement allowing for expedited acquisition of customized medications and compounds over a 5 year ordering period. Under the agreement, the company has received calls to deliver various pharmaceuticals to Walter Reed National Military Medical Center and other area military facilities that urgently require specialized drugs and shortage pharmaceuticals to treat personnel. The blanket agreement aims to streamline procurement of these customized medical supplies that directly support patient care across the Defense Health Agency's network of military hospitals and clinics.

SBA capabilities narrative

The Compounding Center Inc (TCC Inc) has been a nationally licensed pharmaceutical wholesale distributor since 2003. Our government clients include but are not limited to, the Department of Defense, Veterans Administrations, Health and Human Services and Department of Prisons. Commercial clients include hospitals, surgery centers, research companies and veterinary health facilities. While we currently work with over 200 government facilities, we still maintain small business values in caring for our customers first, providing medicine at a fair price, and giving a lifetime of quality service.

Quick answers

Is The Compounding Center Inc. registered in SAM.gov?

Yes. The Compounding Center Inc.'s SAM.gov registration is active through May 18, 2027.

What is The Compounding Center Inc.'s CAGE code?

The Compounding Center Inc.'s CAGE code is 4QSF3, and its Unique Entity ID (UEI) is J69ERCPB7369.

How much has The Compounding Center Inc. received in federal contracts?

Federal contracts obligated $53,795 to The Compounding Center Inc. in fiscal years 2023 through 2027.

What is The Compounding Center Inc.'s most recent federal award?

The Compounding Center Inc.'s most recent federal contract award is Compounding center INC:1297768 [23-004077] trialysis slim cath (75N90023P00151), from NIH Clinical Center, on January 25, 2023.

On GovTribe

See The Compounding Center Inc.'s full federal record

  • Federal contract awards
  • IDV awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe